Related Experiment Videos
Pharmacokinetic and pharmacodynamic studies with long-acting propranolol
British Journal of Clinical Pharmacology
|August 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers.
Proceedings of the National Academy of Sciences of the United States of America·2000
Evolutionary conservation of redundancy between a diverged pair of forkhead transcription factor homologues.
Development (Cambridge, England)·2000
Physical characteristics of the ECAT EXACT3D positron tomograph.
Physics in medicine and biology·2000
Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
The Journal of clinical endocrinology and metabolism·2000
Clinical relevance of pharmacogenomic information for improving prescribing practices in acutely admitted older medical patients.
British journal of clinical pharmacology·2026
Potential drug-drug interactions and clinical outcomes among people living with HIV with comorbidities: A multicentre retrospective cohort study.
British journal of clinical pharmacology·2026
Hypertension in obesity: A focus on individualized pharmacotherapy and the role of body composition, on behalf of the European Society of Hypertension Working Group on Diabetes and Metabolic Risk Factors and Working Group on Lifestyle, Cardiovascular Pharmacotherapy and Adherence.
British journal of clinical pharmacology·2026
New therapeutic options for metabolic-associated steatotic liver disease.
British journal of clinical pharmacology·2026
Implementation and use of risk minimization control tools in the EU: A multistakeholder survey.
British journal of clinical pharmacology·2026
Evaluating seltorexant as a treatment option for major depressive disorder.
Expert review of neurotherapeutics·2026
Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis.
International journal of obesity (2005)·2026